Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FXHB4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,444
Award facts
- Contract value 100% obligated
- $24,443.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) pre-filled pens with a ceiling value of $24,443.85 under firm fixed pricing. This is a non-set-aside, competitively awarded contract utilizing a delivery order structure. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company has demonstrated extensive capability in fulfilling federal medical supply requirements through multiple competitive awards covering diverse pharmaceutical products including specialty medications, generic drugs, and brand-name therapeutics across numerous therapeutic domains. The Ozempic delivery order fulfills diabetes medication requirements within the broader framework of the company's comprehensive pharmaceutical support services to defense and veteran healthcare systems. The ultimate completion date for this delivery order is April 25, 2025.
Quick answers
Who was awarded contract SPE2DB25FXHB4?
SPE2DB25FXHB4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FXHB4 worth?
The government has obligated $24,444 on SPE2DB25FXHB4.
Is contract SPE2DB25FXHB4 an order under another contract?
Yes. SPE2DB25FXHB4 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXHB4 competed?
The extent of competition for SPE2DB25FXHB4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award